Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7790745 Tetrahydroisoquinoline LXR Modulators

Patent 7790745 was granted and assigned to Bristol-Myers Squibb on September, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Bristol-Myers Squibb

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

77907450

Patent Inventor Names

Ellen K. Kick0

Wu Yang0

Yufeng Wang0

Date of Patent

September 7, 2010

Patent Application Number

115827840

Date Filed

October 18, 2006

Patent Citations Received

‌

US Patent 11925626 Pharmaceutical formulations containing relacorilant, a heteroaryl-ketone fused azadecalin compound

‌

US Patent 11660295 Glucocorticoid receptor modulators to treat cervical cancer

‌

US Patent 11684612 Therapeutic uses of relacorilant, a heteroaryl-ketone fused azadecalin glucocorticoid receptor modulator

‌

US Patent 11878956 Metal salts and uses thereof

‌

US Patent 11903945 Methods of treating antipsychotic-induced weight gain with miricorilant

Patent Primary Examiner

‌

Zinna N. Davis

Patent abstract

A compound of formula I

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7790745 Tetrahydroisoquinoline LXR Modulators

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API